“Helicobacter pylori treatment guideline: An Indian perspective”: Letter to the editor

Treatment guidelines in many countries for Helicobacter pylori (H. pylori) may differ. Owing to the various characteristics of bacteria, clinical manifestations, resistance to antibiotics and recurrence rate, treatment regimens may change. In this letter, we would like to give an Indian perspective...

Descripción completa

Detalles Bibliográficos
Autores principales: Swarnakar, Raktim, Yadav, Shiv Lal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9602215/
https://www.ncbi.nlm.nih.gov/pubmed/36312482
http://dx.doi.org/10.12998/wjcc.v10.i29.10817
_version_ 1784817259401707520
author Swarnakar, Raktim
Yadav, Shiv Lal
author_facet Swarnakar, Raktim
Yadav, Shiv Lal
author_sort Swarnakar, Raktim
collection PubMed
description Treatment guidelines in many countries for Helicobacter pylori (H. pylori) may differ. Owing to the various characteristics of bacteria, clinical manifestations, resistance to antibiotics and recurrence rate, treatment regimens may change. In this letter, we would like to give an Indian perspective on H. pylori treatment guidelines.
format Online
Article
Text
id pubmed-9602215
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-96022152022-10-27 “Helicobacter pylori treatment guideline: An Indian perspective”: Letter to the editor Swarnakar, Raktim Yadav, Shiv Lal World J Clin Cases Letter to the Editor Treatment guidelines in many countries for Helicobacter pylori (H. pylori) may differ. Owing to the various characteristics of bacteria, clinical manifestations, resistance to antibiotics and recurrence rate, treatment regimens may change. In this letter, we would like to give an Indian perspective on H. pylori treatment guidelines. Baishideng Publishing Group Inc 2022-10-16 2022-10-16 /pmc/articles/PMC9602215/ /pubmed/36312482 http://dx.doi.org/10.12998/wjcc.v10.i29.10817 Text en ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
spellingShingle Letter to the Editor
Swarnakar, Raktim
Yadav, Shiv Lal
“Helicobacter pylori treatment guideline: An Indian perspective”: Letter to the editor
title “Helicobacter pylori treatment guideline: An Indian perspective”: Letter to the editor
title_full “Helicobacter pylori treatment guideline: An Indian perspective”: Letter to the editor
title_fullStr “Helicobacter pylori treatment guideline: An Indian perspective”: Letter to the editor
title_full_unstemmed “Helicobacter pylori treatment guideline: An Indian perspective”: Letter to the editor
title_short “Helicobacter pylori treatment guideline: An Indian perspective”: Letter to the editor
title_sort “helicobacter pylori treatment guideline: an indian perspective”: letter to the editor
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9602215/
https://www.ncbi.nlm.nih.gov/pubmed/36312482
http://dx.doi.org/10.12998/wjcc.v10.i29.10817
work_keys_str_mv AT swarnakarraktim helicobacterpyloritreatmentguidelineanindianperspectivelettertotheeditor
AT yadavshivlal helicobacterpyloritreatmentguidelineanindianperspectivelettertotheeditor

Ejemplares similares